机构:[1]Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy[2]Centre for Public Health, Queen’s University Belfast, Belfast, UK[3]Latin American Institute for Brain Health (BrainLat), Universidad Adolfo Ibanez, Santiago, Chile[4]Cognitive Neuroscience Center (CNC), Universidad de San Andrés, Buenos Aires, Argentina[5]National Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina[6]Global Brain Health Institute (GBHI), San Francisco, California, and Dublin, Ireland[7]Brain and Mind Centre, School of Medical Sciences, University of Sydney, Sydney, New South Wales, Australia[8]Department of Medicine, University of Alberta, Canada[9]Neuroscience and Mental Health Institute, University of Alberta, Edmonton, Alberta, Canada[10]Dementia Care and Research Center, Peking University Institute of Mental Health (Sixth Hospital), Beijing, China[11]Beijing Dementia Key Lab, National Health Commission Key Laboratory of Mental Health, Beijing, China[12]National Clinical Research Center for Mental Disorders, Beijing, China[13]Innovation Center for Neurological Disorders, Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China神经科系统神经内科首都医科大学宣武医院[14]Department of Pathology, The First Affiliated Hospital and School of Medicine, Zhejiang University, Hangzhou, China浙江大学医学院附属第一医院[15]China National Clinical Research Center for Neurological Disease, Beijing Tiantan Hospital, Capital Medical University, Beijing, China首都医科大学附属天坛医院[16]Tianjin Huanhu Hospital, Tianjin, China[17]Tianjin Dementia Institute, Tianjin, China[18]Centre for Age-Related Medicine (SESAM), Stavanger University Hospital, Stavanger, Norway[19]Semillero de Neurociencias y Envejecimiento, Ageing Institute, Medical School, Pontificia Universidad Javeriana, Bogotá, Colombia[20]Faculty of Health Sciences, University of Stavanger, Stavanger, Norway[21]Nizam’s Institute of Medical Sciences, Hyderabad, India[22]Parkinson’s Research Alliance of India, India[23]Department of Physiology and Pharmacology “Vittorio Erspamer,”, Sapienza University of Rome, Rome, Italy[24]Hospital San Raffaele of Cassino, Cassino, Italy[25]Department of Neuroscience, Imaging and, Clinical Sciences, University G. d’Annunzio of Chieti-Pescara, Chieti, Italy[26]Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan[27]Mayo Clinic Rochester, Rochester, Minnesota, USA[28]Lou Ruvo Center for Brain Health, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA[29]Department of Old Age Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK
Dementia with Lewy bodies (DLB) research has seen a significant growth in international collaboration over the last three decades. However, researchers face a challenge in identifying large and diverse samples capable of powering longitudinal studies and clinical trials. The DLB research community has begun to focus efforts on supporting the development and harmonization of consortia, while also continuing to forge networks within which data and findings can be shared. This article describes the current state of DLB research collaborations on each continent. We discuss several established DLB cohorts, many of whom have adopted a common framework, and identify emerging collaborative initiatives that hold the potential to expand DLB networks and diversify research cohorts. Our findings identify geographical areas into which the global DLB networks should seek to expand, and we propose strategies, such as the creation of data-sharing platforms and the harmonization of protocols, which may further potentiate international collaboration.
基金:
Royal Society Wolfson Research Merit AwardRoyal Society of London; Wolfson Foundation; Royal SocietyRoyal Society of LondonEuropean Commission; National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London; European H2020 Marie S. Curie ITN-ETN grant; Canadian Institutes for Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Lewy body Dementia Team of the Canadian Consortium on Neurodegeneration of Aging (CCNA); Michael J. Fox Foundation; TakedaTakeda Pharmaceutical Company Ltd [CW2680521]; CONICETConsejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); ANID/FONDAP [15150012]; ANID/Fondecyt [1210195]; Sistema General de Regalias [BPIN2018000100059]; Universidad del Valle [CI 5316]; MULTI-PARTNER CONSORTIUM TO EXPAND DEMENTIA RESEARCH IN LATIN AMERICA (ReDLat) by National Institutes of Health, National Institutes of Aging [R01 AG057234]; MULTI-PARTNER CONSORTIUM TO EXPAND DEMENTIA RESEARCH IN LATIN AMERICA (ReDLat) by Alzheimer's Association [SG-20-725707]; MULTI-PARTNER CONSORTIUM TO EXPAND DEMENTIA RESEARCH IN LATIN AMERICA (ReDLat) by Tau Consortium; MULTI-PARTNER CONSORTIUM TO EXPAND DEMENTIA RESEARCH IN LATIN AMERICA (ReDLat) by Global Brain Health Institute; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UO1 NS100610, P30 AG062428]; Douglas Herthel DVM Memorial Research Fund; Jane and Lee Seidman Fund; Brain Canada; Alzheimer's AssociationAlzheimer's Association [GBHI ALZ UK-20-639295]
第一作者机构:[1]Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy
共同第一作者:
通讯作者:
通讯机构:[2]Centre for Public Health, Queen’s University Belfast, Belfast, UK[*1]Kane, Centre for Public Health,Queen’s University Belfast, Institute of Clinical Sciences, Royal Victoria Hospital, Belfast BT126BA, UK.
推荐引用方式(GB/T 7714):
Fabrizia D’Antonio,Joseph P.M. Kane,Agustin Ibañez,et al.Dementia with Lewy bodies research consortia: A global perspective from the ISTAART Lewy Body Dementias Professional Interest Area working group[J].ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING.2021,13(1):doi:10.1002/dad2.12235.
APA:
Fabrizia D’Antonio,Joseph P.M. Kane,Agustin Ibañez,Simon J.G. Lewis,Richard Camicioli...&the ISTAART Lewy body dementias Consortia Working Group.(2021).Dementia with Lewy bodies research consortia: A global perspective from the ISTAART Lewy Body Dementias Professional Interest Area working group.ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING,13,(1)
MLA:
Fabrizia D’Antonio,et al."Dementia with Lewy bodies research consortia: A global perspective from the ISTAART Lewy Body Dementias Professional Interest Area working group".ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING 13..1(2021)